Information from the European medicines regulatory body regarding the use of combined oral contraceptives, is in line with advice the Ministry of Health has given to New Zealand women since 1996.
The European Agency for the Evaluation of Medicinal Products (EMEA) has published its assessment on combined oral contraceptives and blood clots.
It advises there is a very small risk of clots with all combined oral contraceptives and that the risk of developing a clot is higher in the first year. The EMEA confirms the risk of third generation is approximately twice that of second generation pills.